Skip to main content
OpenTrials
Completed

NCT Number: NCT02028832

Pediatric Integrative Medicine Trial Pilot

This study will investigate if adding complementary therapies such as acupuncture, massage and reiki to inpatient pediatric care is feasible and what the effects are on outcomes such as patient symptoms, cost, safety, satisfaction and length of stay.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 16 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Stollery Childrens' Hospital

Edmonton, Alberta, T6G 2B7, Canada

About this study

Study Objective: To determine if a pediatric integrative medicine (PIM) service is effective in reducing overall symptoms of pain, nausea/vomiting, and/or anxiety (PNVA), length of stay, and costs, in hospitalized children when compared to conventional care. In this context, "integrative" refers to a combined approach of complementary and conventional medical therapies in an evidence-based fashion.

Design: cluster trial; 2-arm controlled evaluation study in pediatric oncology, general pediatrics and pediatric cardiology. Intervention will be offered during a 6-month PIM period following a 6 month control period.

Population: Inclusion criteria: (i) In-patients in participating division and (ii) informed consent/assent. Exclusion criteria: (i) lack of parent participation, fluency in English, or informed consent

Intervention: Recommendations for specific CAM therapies will be determined by a staff PIM pediatrician. Any combination of the following CAM therapies (dose, duration, amount to be based on patient need as assessed by CAM provider, patient, and parent): acupuncture/acupressure, massage, Reiki; all are to be offered in addition to usual care.

Control: Usual care.

Outcomes: Primary outcome: feasibility (i.e enrollment); Secondary outcomes: (i) PNVA symptom management, (ii) need for conventional pharmacotherapy, (iii) adverse events; (iv) parent and health care provider satisfaction with care provided, v) length of stay; and vi) cost-effectiveness (analysis of this outcome to be limited to patients admitted for at least 2 days and for not more than 30 days).

Significance: To our knowledge, this study will be the first comparative effectiveness trial to assess the impact of PIM for hospitalized children with cancer.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • (i) all children, aged 0-16 years, who are admitted to Pediatric Oncology, General Pediatrics and Pediatric Cardiology at the Stollery Children's Hospital, Edmonton, Canada who
  • (ii) can communicate in English; and
  • (iii) give informed consent/assent

Exclusion criteria

  • (i) cannot communicate in English;
  • (ii) lack of parent availability to participate; or
  • iii) lack of informed consent.

Treatment and study plan

PIM consult and service provision

Procedure

If service is requested, treatment options include acupuncture/acupressure, massage, and reiki

usual care

Procedure

Usual care consists of all conventional care options in pediatric oncology including medication and other therapies.

Primary outcomes

  1. Enrollment

    Time frame: up to 5 days

    Enrollment of study participants over length of study which will inform conduct of a larger study in this population

Secondary outcomes

  1. Change in pain

    Time frame: up to 5 days

    For pre-verbal children: Faces, Legs, Activity, Cry, Consolability tool Verbal children: faces Pain Scale-Revised

  2. Change in nausea/vomiting

    Time frame: up to 5 days

    Baxter Retching Faces scale

  3. Change in anxiety

    Time frame: up to 5 days

    Pediatrics Anxiety Faces scale

  4. Incidence of adverse events

    Time frame: up to 5 days

    BC Children's Hospital Patient Safety Questionnaire; Canadian Pediatric Trigger tool

  5. Parent satisfaction with patient care

    Time frame: up to 5 days

    Hospital's standardized satisfaction survey; State-Trait Anxiety Invenvtory

  6. Length of hospital stay

    Time frame: up to 5 days

Other outcomes

  1. Resource Utilization/Cost

    Time frame: Analysis of this outcome to be limited to patients admitted for at least 2 days and for not more than 30 days

    Resource utilization and related costs will be compared between study arms

Sponsors and collaborators

Lead sponsor

University of Alberta

Other

Collaborators

  • Lotte & John Hecht Memorial Foundation

Registry information

Official study title

Pilot Study of Pediatric Integrative Medicine in Pediatric Oncology, General Pediatrics and Pediatric Cardiology

Acronym: PIM

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Jan 7, 2014
Registry last updated
May 8, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.